Company or ticker...

Nurix Therapeutics

Nurix develops targeted protein modulation drugs for cancer and immune diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

NRIX

1.8B

4.2

7

-15.05%

Key Facts

M. Cap

PS

PE

YTD

1.8B

4.2

7

-15.05%

10MA

20MA

50MA

200MA

$NRIX